Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis. Manzer HS, Villarreal RI, Doran KS. PLoS Pathog 2022;18:e1010397.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Manzer HS, Villarreal RI, Doran KS. Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis. PLoS Pathog 2022;18:e1010397.
PMID: 35316308